Published date: 7 July 2022

Last edited date: 27 January 2023

Awarded contract - This means that the contract has been awarded to a supplier.


Closing: 4 May 2022, 7pm

Contract summary

Industry

  • Research and experimental development services - 73100000

Location of contract

East Midlands

Value of contract

£76,535.54

Procurement reference

Medicines Discovery Catapult.

Published date

7 July 2022

Closing date

4 May 2022

Closing time

7pm

Contract start date

5 May 2022

Contract end date

5 May 2022

Contract type

Service contract

Procedure type

Single tender action (below threshold)

A direct contract with a single supplier, without competition.

This procedure can be used for procurements below the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

The Medicines Discovery Catapult will conduct an in vivo 18F imaging and toxicity study in naive and cancer xenograft bearing mice of our HER2 targeting apoferritin anti-cancer drug delivery platform.

Award information

Awarded date

5 May 2022

Contract start date

5 May 2022

Contract end date

5 May 2022

Total value of contract

£76,535.54

This contract was awarded to 1 supplier.

MEDICINES DISCOVERY CATAPULT SERVICES LIMITED

Address

Block 35g Mereside,Alderley Park
MACCLESFIELD
Cheshire
SK10 4TG
GB

Reference

Companies House number: 10305216

Value of contract

£76,535.54

Supplier is SME?

Yes

Supplier is VCSE?

No

About the buyer

Contact name

Guy Wilding

Address

Kings Meadow Campus, Lenton Lane
NOTTINGHAM
NG72NR
England

Telephone

0115 951 5151 ext 15151

Email

procurement@nottingham.ac.uk